5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole
Names | |
---|---|
IUPAC name
(2R,3R,4S,5R)-2-(5,6-Dichlorobenzimidazol-1-yl)-5-(hydroxymethyl)oxolane-3,4-diol | |
Other names
DRB | |
Identifiers | |
53-85-0 | |
3D model (Jmol) | Interactive image |
ChEMBL | ChEMBL375530 |
ChemSpider | 5683 |
DrugBank | DB08473 |
5178 | |
PubChem | 5894 |
| |
| |
Properties | |
C12H12Cl2N2O4 | |
Molar mass | 319.14 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) is a chemical compound that inhibits transcription elongation by RNA Polymerase II. Sensitivity to DRB is dependent on DRB sensitivity inducing factor (DSIF), negative elongation factor (NELF), and positive transcription elongation factor b (P-TEFb). DRB is a nucleoside analog and also inhibits some protein kinases.[1]
References
- ↑ Yamaguchi, Y.; Takagi, T.; Wada, T.; Yano, K.; Furuya, A.; Sugimoto, S.; Hasegawa, J.; Handa, H. (1999). "NELF, a Multisubunit Complex Containing RD, Cooperates with DSIF to Repress RNA Polymerase II Elongation.". Cell. 97 (1): 41–51. doi:10.1016/S0092-8674(00)80713-8. PMID 10199401.
This article is issued from Wikipedia - version of the 6/17/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.